237 related articles for article (PubMed ID: 14527087)
1. Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis.
Yu S; Rao S; Reddy JK
Curr Mol Med; 2003 Sep; 3(6):561-72. PubMed ID: 14527087
[TBL] [Abstract][Full Text] [Related]
2. Peroxisomal beta-oxidation and steatohepatitis.
Rao MS; Reddy JK
Semin Liver Dis; 2001; 21(1):43-55. PubMed ID: 11296696
[TBL] [Abstract][Full Text] [Related]
3. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype.
Hashimoto T; Fujita T; Usuda N; Cook W; Qi C; Peters JM; Gonzalez FJ; Yeldandi AV; Rao MS; Reddy JK
J Biol Chem; 1999 Jul; 274(27):19228-36. PubMed ID: 10383430
[TBL] [Abstract][Full Text] [Related]
4. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system.
Reddy JK; Hashimoto T
Annu Rev Nutr; 2001; 21():193-230. PubMed ID: 11375435
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis.
Reddy JK
Am J Physiol Gastrointest Liver Physiol; 2001 Dec; 281(6):G1333-9. PubMed ID: 11705737
[TBL] [Abstract][Full Text] [Related]
6. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting.
Hashimoto T; Cook WS; Qi C; Yeldandi AV; Reddy JK; Rao MS
J Biol Chem; 2000 Sep; 275(37):28918-28. PubMed ID: 10844002
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis.
Yeldandi AV; Rao MS; Reddy JK
Mutat Res; 2000 Mar; 448(2):159-77. PubMed ID: 10725470
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
[TBL] [Abstract][Full Text] [Related]
9. PPAR: a mediator of peroxisome proliferator action.
Green S
Mutat Res; 1995 Dec; 333(1-2):101-9. PubMed ID: 8538617
[TBL] [Abstract][Full Text] [Related]
10. Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha.
Cook WS; Yeldandi AV; Rao MS; Hashimoto T; Reddy JK
Biochem Biophys Res Commun; 2000 Nov; 278(1):250-7. PubMed ID: 11071880
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of peroxisome proliferator-activated receptor-alpha (PPARalpha)-regulated genes in liver in the absence of peroxisome proliferation in mice deficient in both L- and D-forms of enoyl-CoA hydratase/dehydrogenase enzymes of peroxisomal beta-oxidation system.
Jia Y; Qi C; Zhang Z; Hashimoto T; Rao MS; Huyghe S; Suzuki Y; Van Veldhoven PP; Baes M; Reddy JK
J Biol Chem; 2003 Nov; 278(47):47232-9. PubMed ID: 14500732
[TBL] [Abstract][Full Text] [Related]
12. Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism.
Fan CY; Pan J; Usuda N; Yeldandi AV; Rao MS; Reddy JK
J Biol Chem; 1998 Jun; 273(25):15639-45. PubMed ID: 9624157
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptors: finding the orphan a home.
Green S; Wahli W
Mol Cell Endocrinol; 1994 Apr; 100(1-2):149-53. PubMed ID: 8056148
[TBL] [Abstract][Full Text] [Related]
14. Elevated basal expression of liver peroxisomal beta-oxidation enzymes and CYP4A microsomal fatty acid omega-hydroxylase in STAT5b(-/-) mice: cross-talk in vivo between peroxisome proliferator-activated receptor and signal transducer and activator of transcription signaling pathways.
Zhou YC; Davey HW; McLachlan MJ; Xie T; Waxman DJ
Toxicol Appl Pharmacol; 2002 Jul; 182(1):1-10. PubMed ID: 12127257
[TBL] [Abstract][Full Text] [Related]
15. Hepatic peroxisomal fatty acid beta-oxidation is regulated by liver X receptor alpha.
Hu T; Foxworthy P; Siesky A; Ficorilli JV; Gao H; Li S; Christe M; Ryan T; Cao G; Eacho P; Michael MD; Michael LF
Endocrinology; 2005 Dec; 146(12):5380-7. PubMed ID: 16123164
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
Latruffe N; Vamecq J
Biochimie; 1997; 79(2-3):81-94. PubMed ID: 9209701
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease.
Yeon JE; Choi KM; Baik SH; Kim KO; Lim HJ; Park KH; Kim JY; Park JJ; Kim JS; Bak YT; Byun KS; Lee CH
J Gastroenterol Hepatol; 2004 Jul; 19(7):799-804. PubMed ID: 15209628
[TBL] [Abstract][Full Text] [Related]
18. Increased peroxisomal fatty acid beta-oxidation and enhanced expression of peroxisome proliferator-activated receptor-alpha in diabetic rat liver.
Asayama K; Sandhir R; Sheikh FG; Hayashibe H; Nakane T; Singh I
Mol Cell Biochem; 1999 Apr; 194(1-2):227-34. PubMed ID: 10391144
[TBL] [Abstract][Full Text] [Related]
19. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.
Belury MA; Moya-Camarena SY; Sun H; Snyder E; Davis JW; Cunningham ML; Vanden Heuvel JP
Toxicol Appl Pharmacol; 1998 Aug; 151(2):254-61. PubMed ID: 9707502
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-α signaling in hepatocarcinogenesis.
Misra P; Viswakarma N; Reddy JK
Subcell Biochem; 2013; 69():77-99. PubMed ID: 23821144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
